Article
Pharmacogenetics of Childhood Acute Lymphoblastic Leukemia.
2003-06-01
Abstract excerpt
Patients vary widely in their responses to drug therapy, often manifested as adverse drug reactions, drug resistance or drug-associated toxicity. Functional polymorphisms in genes encoding enzymes, which are involved in drug action, may underlie these differences thus offering a powerful tool in predicting a treatment outcome. Several studies have addressed the potential for tailoring individual acute lymphoblasti...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ce1b8931-3a0b-5608-9a74-71004ac136c2
- DOI
- 10.2174/1570160033476322
